Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gabbianelli, M
Right arrow Articles by Lyman, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gabbianelli, M
Right arrow Articles by Lyman, S
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors

M Gabbianelli, E Pelosi, E Montesoro, M Valtieri, L Luchetti, P Samoggia, L Vitelli, T Barberi, U Testa and S Lyman

Department of Hematology-Oncology, Instituto Superiore di Sanita, Rome, Italy.

We have evaluated the effects of the flt3 receptor ligand (FL) on hematopoietic progenitors/stem cells (HPCs/HSCs) stringently purified from adult peripheral blood and grown in different culture systems. In these experiments HPCs/HSCs were treated with FL +/- kit ligand (KL) +/- monocyte colony-stimulatory factor (M-CSF). In clonogenetic HPC culture supplemented with interleukin-3 (IL-3)/granulomonocyte-CSF (GM- CSF)/erythropoietin (Epo), FL potentiates colony-forming unit (CFU)-GM proliferation in terms of colony number and size, but exerts little effect on burst-forming units-erythroid (BFU-E) and CFU-granulocyte erythroid megakaryocyte macrophage (CFU-GEMM) growth, whereas KL enhances the proliferation of all HPC types; combined FL+KL +/- M-CSF treatment causes a striking shift of CFU-GM colonies from granulocytic to monocytic differentiation. In liquid suspension HPC culture, FL alone induces differentiation along the monocytic and to a minor extent the basophilic lineages, whereas M-CSF alone stimulates prevalent monocytic differentiation but little cell proliferation: combined M- CSF+FL treatment causes both proliferation and almost exclusive monocytic differentiation (97% monocytes in fetal calf serum-rich (FCS+) culture conditions, mean value). At primitive HPC level, FL potentiates the clonogenetic capacity of colony-forming units-blast (CFU-B) and high proliferative potential colony-forming cells (HPP-CFC) in primary and secondary culture; KL exerts a similar action, and additive effects are induced by FL combined with KL. More important, addition of FL alone causes a significant amplification of the number of long-term culture-initiating cells (LTC-ICs), ie, putative repopulating HSCs, whereas this effect is not induced by KL. The FL effects correlate with flt3 mRNA expression in HPCs differentiating throught the erythroid or GM pathway in liquid suspension culture: (1) flt3 mRNA is expressed in freshly purified, resting HPCs; after growth factor stimulus the message (2) is abruptly down-modulated in HPC erythroid differentiation, but (3) is sustainedly expressed through HPC GM differentiation and abolished in GM precursor maturation. This pattern contrasts with the gradual downmodulation of c-kit through both erythroid and GM HPC differentiation. The results indicate that FL exerts a stimulatory action on primitive HPCs, including a unique expanding effect on putative stem cells, whereas its distal proliferative/differentiative action is largely restricted to CFU-GM and monocytic precursors. The latter effect is potentiated by KL and M- CSF, thus suggesting that the structural similarities of FL, KL, M-CSF, and their tyrosine kinase receptors may mediate positive interactions of these growth factors son monocytic differentiation.

Volume 86, Issue 5, pp. 1661-1670, 09/01/1995
Copyright © 1995 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. Meshinchi and F. R. Appelbaum
Structural and Functional Alterations of FLT3 in Acute Myeloid Leukemia
Clin. Cancer Res., July 1, 2009; 15(13): 4263 - 4269.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. J. Way, H. Dinh, M. R. Keene, K. E. White, F. I. L. Clanchy, P. Lusby, J. Roiniotis, A. D. Cook, A. I. Cassady, D. J. Curtis, et al.
The generation and properties of human macrophage populations from hemopoietic stem cells
J. Leukoc. Biol., May 1, 2009; 85(5): 766 - 778.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Kikushige, G. Yoshimoto, T. Miyamoto, T. Iino, Y. Mori, H. Iwasaki, H. Niiro, K. Takenaka, K. Nagafuji, M. Harada, et al.
Human Flt3 Is Expressed at the Hematopoietic Stem Cell and the Granulocyte/Macrophage Progenitor Stages to Maintain Cell Survival
J. Immunol., June 1, 2008; 180(11): 7358 - 7367.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Li, O. Piloto, H. B. Nguyen, K. Greenberg, K. Takamiya, F. Racke, D. Huso, and D. Small
Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model
Blood, April 1, 2008; 111(7): 3849 - 3858.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Bohannon, W. Cui, R. Cox, R. Przkora, E. Sherwood, and T. Toliver-Kinsky
Prophylactic Treatment with Fms-Like Tyrosine Kinase-3 Ligand after Burn Injury Enhances Global Immune Responses to Infection
J. Immunol., March 1, 2008; 180(5): 3038 - 3048.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Norden-Zfoni, J. Desai, J. Manola, P. Beaudry, J. Force, R. Maki, J. Folkman, C. Bello, C. Baum, S. E. DePrimo, et al.
Blood-Based Biomarkers of SU11248 Activity and Clinical Outcome in Patients with Metastatic Imatinib-Resistant Gastrointestinal Stromal Tumor
Clin. Cancer Res., May 1, 2007; 13(9): 2643 - 2650.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
Y. Huang, M. Kucia, F. Rezzoug, J. Ratajczak, M. K. Tanner, M. Z. Ratajczak, C. L. Schanie, H. Xu, I. Fugier-Vivier, and S. T. Ildstad
Flt3-Ligand-Mobilized Peripheral Blood, but Not Flt3-Ligand-Expanded Bone Marrow, Facilitating Cells Promote Establishment of Chimerism and Tolerance
Stem Cells, April 1, 2006; 24(4): 936 - 948.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Zhu, G. Saberwal, Y. Lu, L. C. Platanias, and E. A. Eklund
The Interferon Consensus Sequence-binding Protein Activates Transcription of the Gene Encoding Neurofibromin 1
J. Biol. Chem., December 3, 2004; 279(49): 50874 - 50885.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. E. Toliver-Kinsky, C. Y. Lin, D. N. Herndon, and E. R. Sherwood
Stimulation of Hematopoiesis by the Fms-Like Tyrosine Kinase 3 Ligand Restores Bacterial Induction of Th1 Cytokines in Thermally Injured Mice
Infect. Immun., June 1, 2003; 71(6): 3058 - 3067.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Miller, V. G. Pillarisetty, A. B. Shah, S. Lahrs, and R. P. DeMatteo
Murine Flt3 Ligand Expands Distinct Dendritic Cells with Both Tolerogenic and Immunogenic Properties
J. Immunol., April 1, 2003; 170(7): 3554 - 3564.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Casella, T. Feccia, C. Chelucci, P. Samoggia, G. Castelli, R. Guerriero, I. Parolini, E. Petrucci, E. Pelosi, O. Morsilli, et al.
Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor
Blood, February 15, 2003; 101(4): 1316 - 1323.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Pelosi, M. Valtieri, S. Coppola, R. Botta, M. Gabbianelli, V. Lulli, G. Marziali, B. Masella, R. Muller, C. Sgadari, et al.
Identification of the hemangioblast in postnatal life
Blood, October 16, 2002; 100(9): 3203 - 3208.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Thiede, C. Steudel, B. Mohr, M. Schaich, U. Schakel, U. Platzbecker, M. Wermke, M. Bornhauser, M. Ritter, A. Neubauer, et al.
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
Blood, May 29, 2002; 99(12): 4326 - 4335.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Chklovskaia, C. Nissen, L. Landmann, C. Rahner, O. Pfister, and A. Wodnar-Filipowicz
Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor {gamma}-chain signaling and inhibited by cyclosporin A
Blood, February 15, 2001; 97(4): 1027 - 1034.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Nakamura, M. Kobayashi, N. Konishi, H. Kawaguchi, S.-i. Miyagawa, T. Sato, H. Toyoda, Y. Komada, S. Kojima, O. Katoh, et al.
Abnormalities of primitive myeloid progenitor cells expressing granulocyte colony-stimulating factor receptor in patients with severe congenital neutropenia
Blood, December 15, 2000; 96(13): 4366 - 4369.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
T. Kimura, J. Wang, H. Minamiguchi, H. Fujiki, S. Harada, K. Okuda, H. Kaneko, S. Yokota, K. Yasukawa, T. Abe, et al.
Signal through gp130 Activated by Soluble Interleukin (IL)-6 Receptor (R) and IL-6 or IL-6R/IL-6 Fusion Protein Enhances Ex Vivo Expansion of Human Peripheral Blood-Derived Hematopoietic Progenitors
Stem Cells, November 1, 2000; 18(6): 444 - 452.
[Abstract] [Full Text]


Home page
BloodHome page
F. Grignani, M. Valtieri, M. Gabbianelli, V. Gelmetti, R. Botta, L. Luchetti, B. Masella, O. Morsilli, E. Pelosi, P. Samoggia, et al.
PML/RARalpha fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype
Blood, August 15, 2000; 96(4): 1531 - 1537.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Vitelli, G. Condorelli, V. Lulli, T. Hoang, L. Luchetti, C. M. Croce, and C. Peschle
A Pentamer Transcriptional Complex Including tal-1 and Retinoblastoma Protein Downmodulates c-kit Expression in Normal Erythroblasts
Mol. Cell. Biol., July 15, 2000; 20(14): 5330 - 5342.
[Abstract] [Full Text]


Home page
BloodHome page
M. Gabbianelli, U. Testa, A. Massa, E. Pelosi, N. M. Sposi, R. Riccioni, L. Luchetti, and C. Peschle
Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate
Blood, June 1, 2000; 95(11): 3555 - 3561.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Wang, S. E. Braun, G. Sonpavde, and K. Cornetta
Antileukemic Activity of Flt3 Ligand in Murine Leukemia
Cancer Res., April 1, 2000; 60(7): 1895 - 1900.
[Abstract] [Full Text]


Home page
BloodHome page
N. Konishi, M. Kobayashi, S.-i. Miyagawa, T. Sato, O. Katoh, and K. Ueda
Defective Proliferation of Primitive Myeloid Progenitor Cells in Patients With Severe Congenital Neutropenia
Blood, December 15, 1999; 94(12): 4077 - 4083.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
B. L. Ziegler, M. Valtieri, G. A. Porada, R. D. Maria, R. Müller, B. Masella, M. Gabbianelli, I. Casella, E. Pelosi, T. Bock, et al.
KDR Receptor: A Key Marker Defining Hematopoietic Stem Cells
Science, September 3, 1999; 285(5433): 1553 - 1558.
[Abstract] [Full Text]


Home page
BloodHome page
C. Chelucci, I. Casella, M. Federico, U. Testa, G. Macioce, E. Pelosi, R. Guerriero, G. Mariani, A. Giampaolo, H.J. Hassan, et al.
Lineage-Specific Expression of Human Immunodeficiency Virus (HIV) Receptor/Coreceptors in Differentiating Hematopoietic Precursors: Correlation With Susceptibility to T- and M-Tropic HIV and Chemokine-Mediated HIV Resistance
Blood, September 1, 1999; 94(5): 1590 - 1600.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. L. Ziegler, R. Muller, M. Valtieri, C. P. Lamping, C. A. Thomas, M. Gabbianelli, C. Giesert, H.-J. Buhring, L. Kanz, and C. Peschle
Unicellular-Unilineage Erythropoietic Cultures: Molecular Analysis of Regulatory Gene Expression at Sibling Cell Level
Blood, May 15, 1999; 93(10): 3355 - 3368.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M.A. Dao, K. Hashino, I. Kato, and J.A. Nolta
Adhesion to Fibronectin Maintains Regenerative Capacity During Ex Vivo Culture and Transduction of Human Hematopoietic Stem and Progenitor Cells
Blood, December 15, 1998; 92(12): 4612 - 4621.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. W. Kennedy and J. L. Abkowitz
Mature monocytic cells enter tissues and engraft
PNAS, December 8, 1998; 95(25): 14944 - 14949.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Kapp, M. Bhatia, D. Bonnet, B. Murdoch, and J. E. Dick
Treatment of Non-Obese Diabetic (NOD)/Severe-Combined Immunodeficient Mice (SCID) With flt3 Ligand and Interleukin-7 Impairs the B-Lineage Commitment of Repopulating Cells After Transplantation of Human Hematopoietic Cells
Blood, September 15, 1998; 92(6): 2024 - 2031.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. L. Abkowitz, M. R. Taboada, K. M. Sabo, and G. H. Shelton
The Ex Vivo Expansion of Feline Marrow Cells Leads to Increased Numbers of BFU-E and CFU-GM but a Loss of Reconstituting Ability
Stem Cells, July 1, 1998; 16(4): 288 - 293.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Lavagna-Sevenier, S. Marchetto, D. Birnbaum, and O. Rosnet
The CBL-related Protein CBLB Participates in FLT3 and Interleukin-7 Receptor Signal Transduction in Pro-B Cells
J. Biol. Chem., June 12, 1998; 273(24): 14962 - 14967.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. S. Gotze, M. Ramirez, K. Tabor, D. Small, W. Matthews, and C. I. Civin
Flt3high and Flt3low CD34+ Progenitor Cells Isolated From Human Bone Marrow Are Functionally Distinct
Blood, March 15, 1998; 91(6): 1947 - 1958.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. D. Lyman and S. E. W. Jacobsen
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Blood, February 15, 1998; 91(4): 1101 - 1134.
[Full Text] [PDF]


Home page
BloodHome page
K. M. Luens, M. A. Travis, B. P. Chen, B. L. Hill, R. Scollay, and L. J. Murray
Thrombopoietin, kit Ligand, and flk2/flt3 Ligand Together Induce Increased Numbers of Primitive Hematopoietic Progenitors From Human CD34+Thy-1+Lin- Cells With Preserved Ability to Engraft SCID-hu Bone
Blood, February 15, 1998; 91(4): 1206 - 1215.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Ebihara, K. Tsuji, S. D. Lyman, X. Sui, M. Yoshida, K. Muraoka, K. Yamada, R. Tanaka, and T. Nakahata
Synergistic Action of Flt3 and gp130 Signalings in Human Hematopoiesis
Blood, December 1, 1997; 90(11): 4363 - 4368.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Ito, Y. Ueda, M. Kokubun, M. Urabe, T. Inaba, H. Mano, H. Hamada, T. Kitamura, H. Mizoguchi, T. Sakata, et al.
Development of a Novel Selective Amplifier Gene for Controllable Expansion of Transduced Hematopoietic Cells
Blood, November 15, 1997; 90(10): 3884 - 3892.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. C. Dooley, M. Xiao, B. K. Oppenlander, J. M. Plunkett, and S. D. Lyman
Flt3 Ligand Enhances the Yield of Primitive Cells After Ex Vivo Cultivation of CD34+ CD38dim Cells and CD34+ CD38dim CD33dim HLA-DR+ Cells
Blood, November 15, 1997; 90(10): 3903 - 3913.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. N. Haylock, M. J. Horsfall, T. L. Dowse, H. S. Ramshaw, S. Niutta, S. Protopsaltis, L. Peng, C. Burrell, I. Rappold, H.-J. Buhring, et al.
Increased Recruitment of Hematopoietic Progenitor Cells Underlies the Ex Vivo Expansion Potential of FLT3 Ligand
Blood, September 15, 1997; 90(6): 2260 - 2272.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. d. Haan and G. V. Zant
Intrinsic and Extrinsic Control of Hemopoietic Stem Cell Numbers: Mapping of a Stem Cell Gene
J. Exp. Med., August 18, 1997; 186(4): 529 - 536.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. S.-C. Juan, I. K. McNiece, G. Van, D. Lacey, C. Hartley, P. McElroy, Y. Sun, J. Argento, D. Hill, X.-Q. Yan, et al.
Chronic Expression of Murine flt3 Ligand in Mice Results in Increased Circulating White Blood Cell Levels and Abnormal Cellular Infiltrates Associated With Splenic Fibrosis
Blood, July 1, 1997; 90(1): 76 - 84.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Rappold, B. L. Ziegler, I. Kohler, S. Marchetto, O. Rosnet, D. Birnbaum, P. J. Simmons, A. C.W. Zannettino, B. Hill, S. Neu, et al.
Functional and Phenotypic Characterization of Cord Blood and Bone Marrow Subsets Expressing FLT3 (CD135) Receptor Tyrosine Kinase
Blood, July 1, 1997; 90(1): 111 - 125.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Albella, J. C. Segovia, and J. A. Bueren
Does the Granulocyte-Macrophage Colony-Forming Unit Content in Ex Vivo-Expanded Grafts Predict the Recovery of the Recipient Leukocytes?
Blood, July 1, 1997; 90(1): 464 - 470.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Piacibello, F. Sanavio, L. Garetto, A. Severino, D. Bergandi, J. Ferrario, F. Fagioli, M. Berger, and M. Aglietta
Extensive Amplification and Self-Renewal of Human Primitive Hematopoietic Stem Cells From Cord Blood
Blood, April 15, 1997; 89(8): 2644 - 2653.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Yonemura, H. Ku, S. D. Lyman, and M. Ogawa
In Vitro Expansion of Hematopoietic Progenitors and Maintenance of Stem Cells: Comparison Between FLT3/FLK-2 Ligand and KIT Ligand
Blood, March 15, 1997; 89(6): 1915 - 1921.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. A. Dao, C. H. Hannum, D. B. Kohn, and J. A. Nolta
FLT3 Ligand Preserves the Ability of Human CD34+ Progenitors to Sustain Long-Term Hematopoiesis in Immune-Deficient Mice After Ex Vivo Retroviral-Mediated Transduction
Blood, January 15, 1997; 89(2): 446 - 456.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R Namikawa, M. Muench, and M. Roncarolo
Regulatory roles of the ligand for Flk2/Flt3 tyrosine kinase receptor on human hematopoiesis
Stem Cells, July 1, 1996; 14(4): 388 - 395.
[Abstract]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1995 by American Society of Hematology         Online ISSN: 1528-0020